219 related articles for article (PubMed ID: 11135668)
1. Mechanism-based design of a protein kinase inhibitor.
Parang K; Till JH; Ablooglu AJ; Kohanski RA; Hubbard SR; Cole PA
Nat Struct Biol; 2001 Jan; 8(1):37-41. PubMed ID: 11135668
[TBL] [Abstract][Full Text] [Related]
2. Double trouble.
Miller WT
Nat Struct Biol; 2001 Jan; 8(1):16-8. PubMed ID: 11135660
[No Abstract] [Full Text] [Related]
3. Bisubstrate analog probes for the insulin receptor protein tyrosine kinase: molecular yardsticks for analyzing catalytic mechanism and inhibitor design.
Hines AC; Parang K; Kohanski RA; Hubbard SR; Cole PA
Bioorg Chem; 2005 Aug; 33(4):285-97. PubMed ID: 16023488
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of a substrate selective p38alpha inhibitor.
Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A.
Hines AC; Cole PA
Bioorg Med Chem Lett; 2004 Jun; 14(11):2951-4. PubMed ID: 15125966
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
7. Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.
Favelyukis S; Till JH; Hubbard SR; Miller WT
Nat Struct Biol; 2001 Dec; 8(12):1058-63. PubMed ID: 11694888
[TBL] [Abstract][Full Text] [Related]
8. A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase.
Klingbeil CK; Gill GN
Arch Biochem Biophys; 1999 Mar; 363(1):27-32. PubMed ID: 10049496
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase.
Madhusudan ; Akamine P; Xuong NH; Taylor SS
Nat Struct Biol; 2002 Apr; 9(4):273-7. PubMed ID: 11896404
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases.
Bell IM; Stirdivant SM; Ahern J; Culberson JC; Darke PL; Dinsmore CJ; Drakas RA; Gallicchio SN; Graham SL; Heimbrook DC; Hall DL; Hua J; Kett NR; Kim AS; Kornienko M; Kuo LC; Munshi SK; Quigley AG; Reid JC; Trotter BW; Waxman LH; Williams TM; Zartman CB
Biochemistry; 2005 Jul; 44(27):9430-40. PubMed ID: 15996097
[TBL] [Abstract][Full Text] [Related]
12. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
[TBL] [Abstract][Full Text] [Related]
13. Is there a catalytic base in the active site of cAMP-dependent protein kinase?
Zhou J; Adams JA
Biochemistry; 1997 Mar; 36(10):2977-84. PubMed ID: 9062128
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
15. Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutants.
Breitenlechner CB; Friebe WG; Brunet E; Werner G; Graul K; Thomas U; Künkele KP; Schäfer W; Gassel M; Bossemeyer D; Huber R; Engh RA; Masjost B
J Med Chem; 2005 Jan; 48(1):163-70. PubMed ID: 15634010
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA.
Kim C; Xuong NH; Taylor SS
Science; 2005 Feb; 307(5710):690-6. PubMed ID: 15692043
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the tyrosine kinase domain of the human insulin receptor.
Hubbard SR; Wei L; Ellis L; Hendrickson WA
Nature; 1994 Dec 22-29; 372(6508):746-54. PubMed ID: 7997262
[TBL] [Abstract][Full Text] [Related]
18. The role of the putative catalytic base in the phosphoryl transfer reaction in a protein kinase: first-principles calculations.
Valiev M; Kawai R; Adams JA; Weare JH
J Am Chem Soc; 2003 Aug; 125(33):9926-7. PubMed ID: 12914447
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.
Krajewski WW; Collins R; Holmberg-Schiavone L; Jones TA; Karlberg T; Mowbray SL
J Mol Biol; 2008 Jan; 375(1):217-28. PubMed ID: 18005987
[TBL] [Abstract][Full Text] [Related]
20. Phosphoryl transfer by a concerted reaction mechanism in UMP/CMP-kinase.
Hutter MC; Helms V
Protein Sci; 2000 Nov; 9(11):2225-31. PubMed ID: 11152133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
